25 related articles for article (PubMed ID: 2183543)
1. Clozapine Augmentation With Antiepileptic Drugs for Treatment-Resistant Schizophrenia: A Meta-Analysis of Randomized Controlled Trials.
Zheng W; Xiang YT; Yang XH; Xiang YQ; de Leon J
J Clin Psychiatry; 2017 May; 78(5):e498-e505. PubMed ID: 28355041
[TBL] [Abstract][Full Text] [Related]
2. Use of anticonvulsants as prophylaxis for seizures in patients on clozapine.
Caetano D
Australas Psychiatry; 2014 Feb; 22(1):78-83. PubMed ID: 23996793
[TBL] [Abstract][Full Text] [Related]
3. Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia.
Alabed S; Latifeh Y; Mohammad HA; Bergman H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD000203. PubMed ID: 29663328
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment of schizophrenic psychoses with haloperidol and valproate.
Dose M; Hellweg R; Yassouridis A; Theison M; Emrich HM
Pharmacopsychiatry; 1998 Jul; 31(4):122-5. PubMed ID: 9754845
[TBL] [Abstract][Full Text] [Related]
5. Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose.
McEvoy JP; Hogarty GE; Steingard S
Arch Gen Psychiatry; 1991 Aug; 48(8):739-45. PubMed ID: 1883257
[TBL] [Abstract][Full Text] [Related]
6. Carbamazepine as an adjunct of antipsychotic therapy.
Dose M; Apelt S; Emrich HM
Psychiatry Res; 1987 Dec; 22(4):303-10. PubMed ID: 3324137
[TBL] [Abstract][Full Text] [Related]
7. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB
Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505
[TBL] [Abstract][Full Text] [Related]
8. Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients.
Hesslinger B; Normann C; Langosch JM; Klose P; Berger M; Walden J
J Clin Psychopharmacol; 1999 Aug; 19(4):310-5. PubMed ID: 10440457
[TBL] [Abstract][Full Text] [Related]
9. Anticonvulsants as adjuncts for the neuroleptic treatment of schizophrenic psychoses: a clinical study with beclamide.
Raptis C; Garcia-Borreguero D; Weber MM; Dose M; Bremer D; Emrich HM
Acta Psychiatr Scand; 1990 Feb; 81(2):162-7. PubMed ID: 2183543
[TBL] [Abstract][Full Text] [Related]
10. The use of carbamazepine in the treatment of schizophrenic and schizoaffective psychoses: a review.
Simhandl C; Meszaros K
J Psychiatry Neurosci; 1992 Mar; 17(1):1-14. PubMed ID: 1349823
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal Antibody Therapy in Autoantibody-Associated Psychotic Disorders and Schizophrenia: Narrative Review of Past and Current Clinical Trials.
Hansen N; Malchow B
Psychiatr Danub; 2023; 35(1):8-15. PubMed ID: 37060587
[TBL] [Abstract][Full Text] [Related]
12. Drug-resistance phenomena in major psychoses: their discrimination and causal mechanisms.
Altamura AC
Clin Neuropharmacol; 1990; 13 Suppl 1():S1-15. PubMed ID: 1974169
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
